Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed

Journal of Thoracic Oncology

Volumn 7, Issue 4, 2012, Pages 766-767

  Christoph, Daniel C ^a   Hoffmann, Andreas Claudius ^b   Gauler, Thomas C ^b,c   Asuncion, Bernadette Reyna ^a   Loewendick, Heike ^b   Peglow, Anja ^b   Hassan, Biftu ^a   Tran, Cindy ^a   Wynes, Murry W ^a   Schuler, Martin ^b,c   Eberhard, Wilfried E ^b,c   Hirsch, Fred R ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c RUHRLANDKLINIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; ERLOTINIB; GEMCITABINE; MITOMYCIN; NAVELBINE; PEMETREXED; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

EID: 84858765821     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182460fa9     Document Type: Article

References (7)

1. Hou J-M, Krebs M, Ward T, et al. Circulating tumour cells, enumeration and beyond. Cancers 2010;2:1236-1250.
2. Pestrin M, Bessi S, Galardi F, et al. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Res Treat 2009;118:523-530.
3. Marrinucci D, Bethel K, Luttgen M, et al. Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Arch Pathol Lab Med 2009;133:1468-1471.
4. Chen CY, Chang YL, Shih JY, et al. Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed. Lung Cancer 2011;74:132-138.
5. Sun J-M, Han J, Ahn JS. Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy. J Thorac Oncol 2011;6:1392-1399.
6. Guo J, Yao F, Lou Y, et al. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR. J Clin Gastroenterol 2011;41:783-788. (Pubitemid 47267766)
7. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.